Suboptimal surveillance for and knowledge of hepatocellular carcinoma among primary care providers

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 4, 2015, Pages 799-804

  McGowan, Christopher E ^a   Edwards, Teresa P ^b   Luong, Mai Uyen T ^a   Hayashi, Paul H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

AFP; Cirrhosis; HCC; Hepatitis B; Hepatitis C; PCP; RCT; Screening; Therapy; US

Indexed keywords

ALPHA FETOPROTEIN; SORAFENIB;

ARTICLE; CANCER EPIDEMIOLOGY; CHEMOEMBOLIZATION; FEMALE; GASTROENTEROLOGIST; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; MALPRACTICE; MEDICAL PRACTICE; MEDICAL SOCIETY; PRIMARY MEDICAL CARE; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE; RADIOFREQUENCY ABLATION; ULTRASOUND; CARCINOMA, HEPATOCELLULAR; CLINICAL PRACTICE; COMPLICATION; EARLY DIAGNOSIS; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; HEALTH SERVICES RESEARCH; LIVER CIRRHOSIS; LIVER NEOPLASMS; PRIMARY HEALTH CARE; PROCEDURES; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; NORTH CAROLINA; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; SURVEYS AND QUESTIONNAIRES;

EID: 84925105647     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.07.056     Document Type: Article

References (28)

1. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022.
2. Omata M., Lesmana L.A., Tateishi R., et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010, 4:439-474.
3. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. JHepatol 2012, 56:908-943.
4. Davila J.A., Weston A., Smalley W., et al. Utilization of screening for hepatocellular carcinoma in the United States. JClin Gastroenterol 2007, 41:777-782.
5. Davila J.A., Morgan R.O., Richardson P.A., et al. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology 2010, 52:132-141.
6. Davila J.A., Henderson L., Kramer J.R., et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med 2011, 154:85-93.
7. Palmer L.B., Kappelman M.D., Sandler R.S., et al. Surveillance for hepatocellular carcinoma in a Medicaid cirrhotic population. JClin Gastroenterol 2013, 47:713-718.
8. Sanyal A., Poklepovic A., Moyneur E., et al. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin 2010, 26:2183-2191.
9. Nguyen T.T., Gildengorin G., Truong A., et al. Factors influencing physicians' screening behavior for liver cancer among high-risk patients. JGen Intern Med 2007, 22:523-526.
10. Khalili M., Guy J., Yu A., et al. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Dig Dis Sci 2011, 56:1516-1523.
11. Ferrante J.M., Winston D.G., Chen P.H., et al. Family physicians' knowledge and screening of chronic hepatitis and liver cancer. Family Med 2008, 40:345-351.
12. Association of American Medical Colleges, Center for Workforce Studies. State Physician Workforce Data Book; 2011. Available from: Accessed: March 25,2014. https://www.aamc.org/download/263512/data/statedata2011.pdf.
13. United States Census Bureau. State and county quickfacts: US Department of Commerce. 2014. Available from: Accessed: March 25,2014. http://quickfacts.census.gov/qfd/states/37000.html.
14. Dillman D., Smyth J., Christian J. Internet, mail, and mixed-mode surveys: the tailored design method 2009, John Wiley & Sons, Hoboken, NJ.
15. Chen M.S., Li J.Q., Zheng Y., et al. Aprospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006, 243:321-328.
16. Huang J., Yan L., Cheng Z., et al. Arandomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010, 252:903-912.
17. Feng K., Yan J., Li X., et al. Arandomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. JHepatol 2012, 57:794-802.
18. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trialof transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002, 35:1164-1171.
19. Llovet J., Ricci S., Mazzaferro V., et al. Randomized phase III trail of sorafenib versus placebo in patients with advanced hepatocellular carcinoma. JClin Oncol 2007, 25(Suppl 18):LBA1.
20. Zhang B.H., Yang B.H., Tang Z.Y. Randomized controlled trial of screening for hepatocellular carcinoma. JCancer Res Clin Oncol 2004, 130:417-422.
21. Singal A.G., Pillai A., Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med 2014, 11:e1001624.
22. United States Census Bureau. State and county quickfacts: USDepartment of Commerce; 2013. Available from: Accessed: March 25,2014. http://quickfacts.census.gov/qfd/states/00000.html.
23. Sherman M., Bruix J., Porayko M., et al. Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations. Hepatology 2012, 56:793-796.
24. Lederle F.A., Pocha C. Screening for liver cancer: the rush to judgment. Ann Intern Med 2012, 156:387-389.
25. Kansagara D., Papak J., Pasha A.S., et al. Screening for hepatocellular carcinoma in chronic liver disease: a systematic review. Ann Intern Med 2014, 161:261-269.
26. Cook J.V., Dickinson H.O., Eccles M.P. Response rates in postal surveys of healthcare professionals between 1996 and 2005: an observational study. BMC Health Serv Res 2009, 9:160.
27. McLeod C.C., Klabunde C.N., Willis G.B., et al. Health care provider surveys in the United States, 2000-2010: a review. Eval Health Prof 2013, 36:106-126.
28. Klabunde C.N., Willis G.B., Casalino L.P. Facilitators and barriers tosurvey participation by physicians: a call to action for researchers. Eval Health Prof 2013, 36:279-295.